Navigation Links
Alliance/Merck Ciencia (Science) Hispanic Scholars Program Announced
Date:5/22/2008

$4 MILLION INVESTMENT SUPPORTS AMERICA'S NEXT GENERATION OF SCIENTISTS

WASHINGTON, May 22 /PRNewswire-USNewswire/ -- The National Alliance for Hispanic Health (the Alliance) announced today the establishment of the Alliance/Merck Ciencia Scholars Program, a new partnership improving Hispanic student access to higher education and degrees in science, technology, engineering and math (STEM). The Program is made possible through a $4 million grant from The Merck Company Foundation, the philanthropic arm of the research-based pharmaceutical company Merck & Co., Inc. This is the largest grant to date that The Merck Company Foundation has made to the field of Hispanic education.

The Alliance will work with the Merck Institute for Science Education (MISE) to implement the Program. This partnership builds upon the Alliance's 35-year record of work in the Hispanic community and expertise in supporting youth and improving the science base and the expertise of MISE in improving science education. During the next five years, the Program will provide 50 promising Hispanic high school students from Brownsville, TX; Elizabeth, NJ; and Los Angeles, CA with $42,500 in college scholarships and internship support to pursue STEM degrees. These predominantly Hispanic communities have a history in working with the Alliance and MISE. In addition, 125 Hispanic college students nationwide will receive $2,000 scholarships.

"Building on a distinguished history of Hispanic pioneers in science, a new generation of discovery begins today with this landmark investment of $4 million in Hispanic students," said Dr. Jane L. Delgado, President and CEO of the Alliance today in announcing establishment of the Alliance/Merck Ciencia Hispanic Scholars Program. "It gives us great pride to be working with Merck in opening this new phase of the Alliance's innovative Ciencia initiative to support Hispanic students and improve the nation's science base."

"We are pleased to pa
'/>"/>

SOURCE National Alliance for Hispanic Health
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. New Survey Reveals Hispanic-Americans Are Taking Steps to Better Understand and Manage GERD
2. Researchers find disparities in depression among older Hispanics in US
3. MetLife Foundation Awards $815,000 to Alzheimers Association for Hispanic Outreach and Safety Initiatives
4. Artery Plaque Boosts Hispanics Odds for Stroke
5. Race Central Launches Vigor Latino 5K Run/Walk, Promoting Hispanic Health, Fun and Fitness
6. AHRQ and Ad Council Encourage Hispanics to Become More Involved in Their Health Care
7. Overweight Hispanic Kids Show Early Markers for Diabetes
8. Overweight Hispanic children shown to have vascular inflammation
9. Fast Food Ads Fueling Obesity Among Hispanic Kids
10. Hispanics have more difficulty controlling diabetes than non-Hispanic whites
11. UH researchers study Hispanic childrens activities, views on places to play
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... BOSTON, Nov. 21 Innerscope Resea... firm specializing in Emotional Response Measureme...utives who will strengthen the,company,s research...,initiatives. , The three appointments, who...de Geoffrey Gill as Chief Financial Officer and Vi...
(Date:11/21/2008)... , COLD SPRING HARBOR, N.Y. (Nov. 21, 2008) Ho...What can the lamprey immune system tell us about e...ations help with efforts to conserve rare species?...duction, and hereditary diseases? Will studies of... , To answer these and other questions in biolog...
(Date:11/21/2008)... WASHINGTON, Nov. 21 New inventio... with a variety of cognitive disabilities lead ful...ience(R) Corporation. Zimman,presented today at t...ington,DC, a meeting organized by The National C...tion to assist people with disabilities. , ...
(Date:11/21/2008)... Winter viruses may be to blame, study suggests ...The season of a baby,s birth may help predict that..., Babies born in autumn -- about four months befo...a 30 percent increased risk of asthma compared to ...study in the first December issue of the American...
Breaking Medicine News(10 mins):Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2Health News:A new world of research possibilities with 'Emerging Model Organisms' 2Health News:New Applications for Cognitive Training 2Health News:Autumn Babies More Prone to Asthma 2Health News:Autumn Babies More Prone to Asthma 3
...s of vitamin C notwithstanding, British researcher...! It is now said that vitamin C reverses pre eclam...e leading contributors to complications in childbi...n lead onto eclampsia which, when left untreated, ...
...hat causes infectious mononucleosis, Epstein-Barr ...o the development of Hodgkin's disease. But no one...BV and Hodgkin's survival, according to researcher... from Northern California Cancer Center in Union C...
...d on more than 1600 women reveals that parathyroid...ne density and cut the risk of fractures in them. ...ium levels in the body. The new aspect of th...ures has opened up the prospect of the hormone bei...
...n from Mayo Foundation in Rochester, Minnesota has...ble metal stents in the digestive tract of people ...ese patients commonly suffer from obstructions and...ke difficulty in swallowing, if the block is in th...
Other Medicine News:
(Date:11/21/2008)... -- Ikaria Holdings, Inc. today announced that it ...New Jersey Technology Council (NJTC), a 1,200-memb...support, networking opportunities, information and...rs. Ikaria earned the award based on criteria incl... provision. , , "We are delighted that the ...
(Date:11/20/2008)...ire/ -- New Jersey American Water has lifted the ...rs in the following municipalities in Middlesex, S...ounty , , , Dunellen , Ediso...South Plainfield , , , , Somerset C...idgewater , Green Brook , Hillsborou...
(Date:11/20/2008)...20 Arpida (SWX:,ARPN) a...ory Committee of the,U.S. Food and Drug Administr...l of intravenous iclaprim, an antibiotic currently...h complicated skin and skin structure infections,...sistant Staphylococcus,aureus (MRSA). , Ar...
(Date:11/20/2008)...re-FirstCall/ -- Duska Therapeutics,Inc., (OTC B...submitted its,pivotal Phase 3 ATPace clinical tri...ssessment (SPA) procedure with the U.S. Food and D...uring an agreement with the FDA, Duska intends to ...cebo-controlled and randomized Phase 3,clinical t...
Breaking Medicine Technology:Ikaria(R) Named Private Company of the Year by New Jersey Technology Council 2New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Mindray to Attend 2007 RSNA Conference in Chicago 6781 1Mindray to Attend 2007 RSNA Conference in Chicago 6781 2Mindray to Attend 2007 RSNA Conference in Chicago 6781 3Genomic Health to Present at 19th Annual Piper Jaffray Health Care Conference 6779 1Genomic Health to Present at 19th Annual Piper Jaffray Health Care Conference 6779 2Eclipsys to Present at the Merrill Lynch Health Services Investor Conference 6777 1Eclipsys to Present at the Merrill Lynch Health Services Investor Conference 6777 2Eclipsys to Present at the Merrill Lynch Health Services Investor Conference 6777 3Danaher Closes Subsequent Offering Period for Tektronix 3B Acquires Over 90 25 of TEK Shares 6775 1Danaher Closes Subsequent Offering Period for Tektronix 3B Acquires Over 90 25 of TEK Shares 6775 2
...s TNF-alpha Production Through Inhibition,of PDE-4...ire/ -- Anacor,Pharmaceuticals, a privately held p... from its placebo-controlled Phase 1 trial of,AN27...gation for,the treatment of psoriasis. The trial s...omparable to existing topical,treatments for psori...
...k, June 06, 2007 /PRNewswire-FirstCall/,-- XTL Bio...ompleted the analysis of results from a Phase I cl...c Hepatitis C. This Phase I,trial was a placebo co... evaluated the safety, tolerability and antiviral ... The study enrolled 56,patients into seven cohorts...
Other Medicine Technology:Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory,Compound, Shows Efficacy in Psoriasis 2XTL Provides Update on Phase I Clinical Trial of XTL-2125 2XTL Provides Update on Phase I Clinical Trial of XTL-2125 3
Inquire
...are is easy to configure for gravimetric calibrati...ndard method or enter your own parameters (number ... QualiTrace automatically manages the calibration ...from the balance to the software, which establishe...
Reservoir, Low Profile, Single Well, Flat Bottom, 90mL Available Sterile
Reagent Basin, 60mL, 5/Box
Medicine Products: